How do you thank someone for saving your life? Ellen Nottingham has had two years to ponder that question.
Diagnosed in the spring of 2016 with acute myeloid leukemia at a large hospital in Seattle, Nottingham was told by a team of three doctors that she had two weeks to live. One of them remained in the room after the other two left and offered a different option, saying quietly, “You could go to Seattle Cancer Care Alliance (SCCA) and see if they have a clinical trial you could join.”
The Atlantic has convened a handful of evenings across the country as part of
its Cancer and the Community series in which researchers, doctors and patient advocates discuss advances in cancer care. On Tuesday, it was Seattle’s turn, with the spotlight on the care and research being carried out at Seattle Cancer Care Alliance (SCCA) and the Fred Hutchinson Cancer Research Institute.
More than a dozen Seattle Cancer Care Alliance (SCCA) and Fred Hutch physicians and researchers who are leaders in breast oncology will be at the San Antonio Breast Cancer Symposium December 4-8. The symposium provides the latest information on the experimental biology, etiology, prevention, diagnosis and therapy of breast cancer and premalignant breast disease.